In this case, miR-153 was found to act as an anti-tumor molecule in colon cancer by suppressing the Indol amine 2,3-dioxygenase 1 (IDO1) enzyme that catalyzes tryptophan kynurenine and 3-hydroxyanthranilic acid immunosuppressive metabolites. This evidence concerns the gene IDO1 and neoplasm.